Alcon Standardizes on Veeva Vault CDMS for Clinical Data Management
July 10 2019 - 7:03AM
Business Wire
Top 20 medical device company selects Vault
CDMS for greater agility in clinical trial management
Veeva Systems (NYSE:VEEV) today announced that Alcon, a global
medical device company specializing in surgical and vision care
products, chose Veeva Vault Clinical Data Management System (CDMS)
as its enterprise clinical data management system for electronic
data capture (EDC).
Veeva Vault CDMS is a suite of clinical data management
applications on a single cloud platform that enables Alcon to
manage studies from build through execution in an integrated way.
Vault EDC, part of Vault CDMS, provides an intuitive interface for
capturing trial data and is designed for flexibility so Alcon can
create study builds faster and make mid-study changes with no
downtime.
As a newly independent company, Alcon had the opportunity to
select modern applications that support its ambitious R&D
program. Vault CDMS meets the specific requirements and fast
development cycles of medical device research while adding
efficiencies in trial data management.
“Rapid study startups are crucial for us because of the quick
development cycles of medical device products,” said Lisa Sauls,
R&D IT director, clinical and regulatory affairs, at Alcon.
“Veeva Vault CDMS is an innovative, high quality solution that
offers speed and the flexibility to accommodate medical device
data.”
“Veeva Vault CDMS helps life sciences companies improve agility
in data management and efficiency from startup through completion,”
said Henry Levy, general manager, Veeva Vault CDMS. “With its move
to Veeva Vault, Alcon has the foundation to speed innovation in eye
care.”
In addition to Vault CDMS, Alcon is adopting Vault PromoMats,
Vault eTMF, Vault CTMS, Vault Submissions, Vault Submissions
Archive, Vault QualityDocs, and Vault Training.
To see how Vault CDMS helps companies cut their EDC study build
times by 40-60%, register for the upcoming webinar on Tuesday, July
16, 2019.
Additional Information
For more on Veeva Vault CDMS, visit: veeva.com/CDMS For more
information on Veeva Vault Medical Device Suite, visit:
veeva.com/MedDevice Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems Follow @veevasystems on Twitter:
twitter.com/veevasystems Like Veeva on Facebook:
facebook.com/veevasystems
About Alcon
Alcon helps people see brilliantly. As the global leader in eye
care with a heritage spanning more than seven decades, Alcon offers
the broadest portfolio of products to enhance sight and improve
people’s lives. Based in Geneva, Switzerland, and Fort Worth,
Texas, the company’s surgical and vision care products touch the
lives of more than 260 million people in over 140 countries each
year living with conditions like cataracts, glaucoma, retinal
diseases and refractive errors. More than 20,000 associates are
enhancing the quality of life through innovative products,
partnerships with eye care professionals and programs that advance
access to quality eye care. Learn more at alcon.com
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the
global life sciences industry. Committed to innovation, product
excellence, and customer success, Veeva serves more than 750
customers, ranging from the world's largest pharmaceutical and
medical device companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices
throughout North America, Europe, Asia, and Latin America. For more
information, visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the
market demand for and acceptance of Veeva’s products and services,
the results from use of Veeva’s products and services, and general
business conditions, particularly in the life sciences industry.
Any forward-looking statements contained in this press release are
based upon Veeva’s historical performance and its current plans,
estimates, and expectations, and are not a representation that such
plans, estimates, or expectations will be achieved. These
forward-looking statements represent Veeva’s expectations as of the
date of this press announcement. Subsequent events may cause these
expectations to change, and Veeva disclaims any obligation to
update the forward-looking statements in the future. These
forward-looking statements are subject to known and unknown risks
and uncertainties that may cause actual results to differ
materially. Additional risks and uncertainties that could affect
Veeva’s financial results are included under the captions, “Risk
Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on
Form 10-Q for the period ended April 30, 2019. This is available on
the company’s website at veeva.com under the Investors section and
on the SEC’s website at sec.gov. Further information on potential
risks that could affect actual results will be included in other
filings Veeva makes with the SEC from time to time.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190710005130/en/
Roger Villareal Veeva Systems 925-264-8885
roger.villareal@veeva.com
Lisa Barbadora Veeva Systems 610-420-3413 pr@veeva.com
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Aug 2024 to Sep 2024
Veeva Systems (NYSE:VEEV)
Historical Stock Chart
From Sep 2023 to Sep 2024